Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular DiseasePhilip C. Robinson, Mark Nidorf, David Liew et al.|The American Journal of Medicine|2021Cited by 122
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trialsAernoud T.L. Fiolet, Peter J. Kelly, Michiel H.F. Poorthuis et al.|EClinicalMedicine|2024Cited by 56
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseaseP.M. Burger, Jeroen Schaap, Jannick A N Dorresteijn et al.|European Journal of Preventive Cardiology|2023Cited by 16